MedPath

Use of Sodium Bicarbonate in Patients Treated With Topiramate

Not Applicable
Conditions
Metabolic Acidosis
Tubular Acidosis; Renal
Epilepsy
Registration Number
NCT03354507
Lead Sponsor
McMaster Children's Hospital
Brief Summary

Effect of oral sodium bicarbonate therapy on renal tubular acidosis in epilepsy patients taking topiramate.

Detailed Description

Children on topiramate are at a risk of renal tubular acidosis and subsequent development of renal stones. Sodium bicarbonate has been shown to reduce renal tubular acidosis in other populations. To date, no data exist on the efficacy of correction of renal tubular acidosis in pediatric patients on topiramate. We are proposing to investigate the efficacy of 4 weeks of oral sodium bicarbonate therapy to reduce tubular acidosis in patients on topiramate.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients with epilepsy receiving oral topiramate for a minimum of 3 months
Exclusion Criteria
  • pre-existing renal impairments (ie nephropathy, primary nephritis)
  • receiving other medications or diet therapies that may influence renal function or urine acidity/ citrate concentration

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Changes in measured urine parametersBaseline, then at 4 weeks

Spot urine sample will be tested for calcium, creatinine and citrate

Secondary Outcome Measures
NameTimeMethod
Changes in measured blood parameters.Baseline, then at 4 weeks

sodium, potassium, chloride, calcium, magnesium, phosphate, bicarbonate, alkaline phosphatase, urea, creatinine, venous blood gas

Changes in frequency of seizures.Baseline, then at 4 weeks

Changes in seizure entries in seizure diary

Trial Locations

Locations (1)

McMaster Children's Hospital

🇨🇦

Hamilton, Ontario, Canada

McMaster Children's Hospital
🇨🇦Hamilton, Ontario, Canada
Mandeep Sidhu, MD
Contact
9055212100
mandeep.sidhu@medportal.ca
Surejini Tharmaradinam, MD
Contact
9055212100
surejini.tharmaradinam@medportal.ca
Vladimir Belostotsky, MD
Principal Investigator
Brandon Meaney, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.